Back to mobile site

Piper Sandler Upgrades Travere Therapeutics (TVTX) to Overweight

April 14, 2026 11:10 AM EDT Send to a Friend
Piper Sandler analyst Allison M. Bratzel upgraded Travere Therapeutics (NASDAQ: TVTX) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login